HC Wainwright Issues Negative Estimate for PRAX Earnings
Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Free Report) – Stock analysts at HC Wainwright dropped their Q1 2025 earnings per share estimates for shares of Praxis Precision Medicines in a research report issued to clients and investors on Monday, March 3rd. HC Wainwright analyst D. Tsao now anticipates that the company will earn ($3.18) per […]
Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Free Report) – Stock analysts at HC Wainwright dropped their Q1 2025 earnings per share estimates for shares of Praxis Precision Medicines in a research report issued to clients and investors on Monday, March 3rd. HC Wainwright analyst D. Tsao now anticipates that the company will earn ($3.18) per […]
